Cardiovascular effects of endothelin-1 and endothelin antagonists in conscious, hypertensive ((mRen-2)27) rats

This publication has 25 references indexed in Scilit:

• Nonpeptide Endothelin Receptor Antagonists. XI. Pharmacological Characterization of SB 234551, a High-Affinity and Selective Nonpeptide ETA Receptor Antagonist
  The Journal of Pharmacology and Experimental Therapeutics, 2025
• Comment on ''Interactions between endothelin-1 and the renin-angiotensin-aldosterone system''
  Cardiovascular Research, 1999
• Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats.
  European Journal of Pharmacology, 1999
• Interactions between endothelin-1 and the renin–angiotensin–aldosterone system
  Cardiovascular Research, 1999
• MULTIPLE COMPARISON PROCEDURES UPDATED
  Clinical and Experimental Pharmacology and Physiology, 1998
• Desensitization of ET_A endothelin receptor‐mediated negative chronotropic response in right atria–species difference and intracellular mechanisms
  British Journal of Pharmacology, 1998
• Effect of Novel Mixed ETA/ETBAntagonists on Responses to ET-1 in Human Small Muscular Pulmonary Arteries
  Pulmonary Pharmacology & Therapeutics, 1998
• Endothelin receptors mediating contraction of rat and human pulmonary resistance arteries: effect of chronic hypoxia in the rat
  British Journal of Pharmacology, 1998
• Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27.
  1996
• Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats
  British Journal of Pharmacology, 1995